On Friday, Ingevity earned a positive adjustment to its Relative Strength (RS) Rating, from 69 to 77.
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the best stocks typically have an 80 or higher RS Rating as they begin their biggest climbs. See if Ingevity can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Ingevity is trying to complete a cup without handle with a 56.30 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal.
Although earnings and sales growth came in at -9% and -15%, respectively, in the latest report, that shows three quarters of improvement for earnings and one for sales.
Ingevity earns the No. 20 rank among its peers in the Chemicals-Specialty industry group. Air Products & Chemicals, Cabot Corp and Element Solutions are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
